<DOC>
	<DOCNO>NCT01781533</DOCNO>
	<brief_summary>To investigate performance software-algorithm base insulin therapy control blood glucose Type 1 diabetic patient .</brief_summary>
	<brief_title>Study Test Software Algorithm Insulin Therapy New Glucose Sensor</brief_title>
	<detailed_description />
	<criteria>Male female age 18 75 year ( inclusive ) Informed consent obtain advised nature study The subject Type 1 diabetes ( define WHO ) least 24 month The subject 's HbA1c &lt; = 10 % Body Mass Index ( BMI ) &lt; = 35 kg/m2 The subject treat continuous subcutaneous insulin infusion least 3 month Subject actively enrol another clinical trial take part study within 30 day Experienced recurrent severe hypoglycaemic unawareness Total daily insulin dose &gt; = 1.4 IU/kg Subject use medication significantly impact glucose metabolism ( oral topical steroid ) except stable least last three month expect remain stable study duration Allergy insulin Lispro A history drug alcohol dependence Any significant concomitant disease endocrine , cardiac , neurological , malignant , pancreatic disease uncontrolled hypertension judge investigator Uncontrolled hypertension rest blood pressure 140/90 mmHg Patient pregnant , breast feeding period study Patient donate blood last 3 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>